Tomas Weitoft
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Osteoarthritis Treatment and Mechanisms
- Systemic Lupus Erythematosus Research
- Musculoskeletal synovial abnormalities and treatments
-
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 18
- Rheumatoid Arthritis Research and Therapies 14
- Musculoskeletal synovial abnormalities and treatments 4
- Osteoarthritis Treatment and Mechanisms 3
-
- Autoimmune and Inflammatory Disorders Research 3
Tomas Weitoft
22 papers receiving 342 citations
Peers
Comparison fields: 5 of 63
- Rheumatology 212
- Hematology 49
- Orthopedics and Sports Medicine 35
- Equine 5
- Rehabilitation 15
Countries citing papers authored by Tomas Weitoft
This map shows the geographic impact of Tomas Weitoft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Weitoft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Weitoft more than expected).
Fields of papers citing papers by Tomas Weitoft
This network shows the impact of papers produced by Tomas Weitoft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Weitoft. The network helps show where Tomas Weitoft may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomas Weitoft, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 6 | |
| 4 | 2021 | 2 | |
| 5 | 2019 | 8 | |
| 6 | 2018 | 8 | |
| 7 | 2018 | 19 | |
| 8 | 2017 | 7 | |
| 9 | 2016 | 14 | |
| 10 | 2016 | 18 | |
| 11 | 2010 | 7 | |
| 12 | 2007 | 17 | |
| 13 | 2006 | 39 | |
| 14 | 2005 | 33 | |
| 15 | 2003 | 21 | |
| 16 | 2000 | 57 | |
| 17 | 1997 | 39 | |
| 18 | Serum concentrations of hyaluronan and proteoglycan in joint disease. Lack of association. | 1991 | 16 |
| 19 | 1988 | 4 | |
| 20 | 1988 | 3 |
About Tomas Weitoft
Tomas Weitoft is a scholar working on Rheumatology, Hematology, Immunology, Orthopedics and Sports Medicine and Cancer Research, having authored 23 papers that have together received 354 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (14 papers), Musculoskeletal synovial abnormalities and treatments (4 papers), Orthopedic Surgery and Rehabilitation (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Osteoarthritis Treatment and Mechanisms (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Asthma and respiratory diseases (3 papers). The work is most often cited by research in Rheumatology (212 citations), Hematology (49 citations), Orthopedics and Sports Medicine (35 citations), Equine (5 citations) and Rehabilitation (15 citations). Tomas Weitoft has collaborated with scholars based in Sweden, Russia and France. Frequent co-authors include Anders Larsson, J Lysholm, Johan Rönnelid, Tore Saxne, Ann Knight, Lars Rönnblom, Kjell Öberg, Marieann Högman, Anna Engström‐Laurent and Linda Mathsson‐Alm. Their work appears in journals such as Annals of the Rheumatic Diseases, Scandinavian Journal of Rheumatology, Scientific Reports, Nitric Oxide and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.